tiprankstipranks
Emcure Pharmaceuticals Limited (IN:EMCURE)
:EMCURE
India Market
EMCURE
Emcure Pharmaceuticals Limited
RESEARCH TOOLSreports

Emcure Pharmaceuticals Limited (EMCURE) Income Statement

2 Followers

Emcure Pharmaceuticals Limited Income Statement

Last quarter (Q4 2024), Emcure Pharmaceuticals Limited's total revenue was ₹20.29B, a decrease of -10.63% from previous quarter. In Q4, Emcure Pharmaceuticals Limited's net income was ₹1.89B. See Emcure Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25
Total Revenue
₹ 78.08B
Gross Profit
₹ 275.05M
Operating Expenses
₹ 34.01B
Depreciation and Amortization
₹ 3.84B
EBITDA
₹ 14.95B
Operating Income
₹ 10.85B
Other Income/Expenses
₹ -1.13B
Pretax Income
₹ 9.71B
Net Income
₹ 6.81B
Per Share Metrics
Basic EPS
₹ 0.43
Diluted EPS
₹ 0.43
Weighted Average Shares Outstanding
 187.04M
Weighted Average Shares Outstanding (Diluted)
 187.04M
Currency in INR

Emcure Pharmaceuticals Limited Earnings and Revenue History